{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:22:32Z","timestamp":1780662152671,"version":"3.54.1"},"reference-count":53,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Fundation of China","award":["81560678"],"award-info":[{"award-number":["81560678"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The overexpression of ABC transporters induced by anticancer drugs has been found to be the main cause of multidrug resistance. It is actually also a strategy by which cancer cells escape being killed. Tetrandrine is a natural product extracted from the stem of Tinospora crispa. In this study, tetrandrine showed synergistic cytotoxic activity in combinational use with chemotherapeutic drugs, such as Doxorubicin, Vincristine, and Paclitaxel, in both drug-induced and MDR1 gene-transfected cancer cells that over-expressed ABCB1\/P-glycoprotein. Tetrandrine stimulated P-glycoprotein ATPase activity, decreased the efflux of [3H]-Paclitaxel and increased the intracellular accumulation of [3H]-Paclitaxel in KB-C2 cells. Furthermore, SW620\/Ad300 and KB-C2 cells pretreated with 1 \u03bcM tetrandrine for 72 h decreased P-glycoprotein expression without changing its cellular localization. This was demonstrated through Western blotting and immunofluorescence analysis. Interestingly, down-regulation of P-glycoprotein expression was not correlated with gene transcription, as the MDR1 mRNA level exhibited a slight fluctuation in SW620\/Ad300 and KB-C2 cells at 0, 24, 48, and 72 h treatment time points. In addition, molecular docking analysis predicted that tetrandrine had inhibitory potential with the ABCB1 transporter. Our results suggested that tetrandrine can antagonize MDR in both drug-selected and MDR1 gene-transfected cancer cells by down regulating the expression of the ABCB1 transporter, followed by increasing the intracellular concentration of chemotherapeutic agents. The combinational therapy using tetrandrine and other anticancer drugs could promote the treatment efficiency of drugs that are substrates of ABCB1.<\/jats:p>","DOI":"10.3390\/molecules24234383","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:50:45Z","timestamp":1575283845000},"page":"4383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1194-3947","authenticated-orcid":false,"given":"Dan","family":"Liao","sequence":"first","affiliation":[{"name":"Key Laboratory for Complementary and Alternative Medicine Experimental Animal Models of Guangxi, Guangxi University of Chinese Medicine, Nanning 530200, China"},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"},{"name":"Institute of Plastic Surgery, Weifang Medical University, Weifang 261041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ning","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-0482","authenticated-orcid":false,"given":"Jing-Quan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A. De","family":"Vera","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"},{"name":"State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-097X","authenticated-orcid":false,"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John\u2019s University, Queens, NY 11439, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2009.04.002","article-title":"Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1\/Pgp and ABCG2\/BCRP\/MXR transporters","volume":"78","author":"Tiwari","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-004-0653-9","article-title":"Multidrug resistance markers p-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: Prognostic implications","volume":"131","author":"Berger","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1025751631115","article-title":"Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy","volume":"81","author":"Rudas","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000226089","article-title":"Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer","volume":"80","author":"Ge","year":"2009","journal-title":"Digestion"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00313020802441683","article-title":"Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK\/T cell lymphoma: Further exploring the role of P53 and WT1 gene","volume":"41","author":"Huang","year":"2009","journal-title":"Pathology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-0463.2008.00974.x","article-title":"Immunohistochemical expression of multidrug resistance proteins in mature T\/NK-cell lymphomas","volume":"116","author":"Saglam","year":"2008","journal-title":"APMIS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI9290","article-title":"Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells","volume":"105","author":"Sullivan","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_12","first-page":"3767","article-title":"ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma","volume":"8","author":"Ohishi","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2141.2004.05319.x","article-title":"MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia","volume":"128","author":"Schaich","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/mol.105.017988","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione dependent drug efflux","volume":"69","author":"Morrow","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3892\/ijmm.2017.2895","article-title":"Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-\u03baB signaling","volume":"39","author":"Lu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.5414\/CP202123","article-title":"Tetrandrine induces apoptosis in gallbladder carcinoma in vitro","volume":"52","author":"Zhu","year":"2014","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_17","first-page":"495","article-title":"Tetrandrine: A potent abrogator of G2 checkpoint function in tumor cells and its mechanism","volume":"20","author":"Sun","year":"2007","journal-title":"Biomed. Environ. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.3892\/ol.2017.5897","article-title":"Tetrandrine triggers an alternative autophagy in DU145 cells","volume":"13","author":"Qiu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_19","first-page":"488","article-title":"Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7\/TAM cells: An experimental research","volume":"33","author":"Chen","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"ref_20","first-page":"4597","article-title":"Reversal of ABCB1-mediated multidrug resistance by Bromo tetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue","volume":"29","author":"Chen","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00001813-199803000-00008","article-title":"The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein","volume":"9","author":"Choi","year":"1998","journal-title":"Anticancer Drugs"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1211\/0022357022115","article-title":"Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells","volume":"55","author":"Liu","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-004-0868-0","article-title":"Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine","volume":"55","author":"Jin","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1248\/bpb.28.1979","article-title":"Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells","volume":"28","author":"Wang","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00432-009-0704-3","article-title":"Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription","volume":"136","author":"Shen","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","article-title":"Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells","volume":"21","author":"Sun","year":"2014","journal-title":"Phytomedicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1568009616666151106120434","article-title":"Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1\u00ae can Overcome Drug Resistance in Osteosarcoma","volume":"16","author":"Fanelli","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_28","first-page":"66","article-title":"Effect and mechanisms of TET on human gastric carcinoma cell line SGC7901 and SGC7901\/ADR","volume":"34","author":"Li","year":"2014","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/1871520615666150113103439","article-title":"Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance","volume":"15","author":"Karthikeyan","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1002\/1097-0142(19931215)72:12<3553::AID-CNCR2820721203>3.0.CO;2-B","article-title":"Clinical Trials of Agents that Reverse Multidrug Resistance. A literature review","volume":"72","author":"Raderer","year":"1993","journal-title":"Cancer"},{"key":"ref_31","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0006-2952(00)00270-7","article-title":"Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs","volume":"59","author":"Vezmar","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/bjc.1993.224","article-title":"Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-estrogens and their major metabolites","volume":"67","author":"Kirk","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_34","first-page":"543","article-title":"Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein","volume":"36","author":"Foxwell","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"ref_35","first-page":"3","article-title":"In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: Review","volume":"17","author":"Bijie","year":"2005","journal-title":"J. Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138945006777709593","article-title":"Pharmacological strategies for overcoming multidrug resistance","volume":"7","author":"Nobili","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: An update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"ref_39","first-page":"749","article-title":"In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576","volume":"61","author":"Mistry","year":"2001","journal-title":"Cancer Res."},{"key":"ref_40","first-page":"4171","article-title":"Reversal of p-glycoprotein mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979","volume":"56","author":"Dantzig","year":"1996","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/17512433.1.3.429","article-title":"New-generation efflux pump inhibitors","volume":"1","author":"Werle","year":"2008","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_42","first-page":"4595","article-title":"In vitro and in vivo reversal of multidrug resistance by GF120918, an acridone carboxamide derivative","volume":"53","author":"Hyafil","year":"1993","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","article-title":"Multidrug Resistance Proteins (MRPs) and Cancer Therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.2174\/1871520617666171016105704","article-title":"Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products","volume":"17","author":"Guo","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_47","first-page":"245","article-title":"A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance","volume":"32","author":"Tian","year":"1997","journal-title":"Yao Xue Xue Bao"},{"key":"ref_48","first-page":"549","article-title":"Reversal effect of TTD on human multidrug resistant KBV200 cell line","volume":"18","author":"Xu","year":"1999","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_49","first-page":"1134","article-title":"Construction and expression analysis of recombinant vector pcDNA3.1+-HIF-1alpha","volume":"23","author":"Fu","year":"2003","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1159\/000487578","article-title":"Voruciclib, a Potent CDK4\/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells","volume":"45","author":"Gupta","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real Time Quantitative PCR and the 2\u2212DDCT Method","volume":"25","author":"Kenneth","year":"2001","journal-title":"Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/23\/4383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:56Z","timestamp":1760189936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/23\/4383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":53,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["molecules24234383"],"URL":"https:\/\/doi.org\/10.3390\/molecules24234383","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}